Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early-Phase Clinical Study Participants.
Journal: Clinical pharmacology in drug development
Published: December 10, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: June 24, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study.
Journal: Journal of the American Academy of Dermatology
Published: December 01, 2023
Dermoscopic features of a solitary fibrofolliculoma on the left cheek.
Journal: Journal of the American Academy of Dermatology
Published: February 15, 2016
Showing 1-4 of 4
Last Updated: 09/26/2026